Long-term effects of a sensitisation campaign on migraine: the Casilino study
- PMID: 20058047
- PMCID: PMC3452285
- DOI: 10.1007/s10194-009-0183-6
Long-term effects of a sensitisation campaign on migraine: the Casilino study
Abstract
In 2003, we conducted a sensitisation campaign on migraine in the Casilino district of Rome, by sending a letter with the ID Migraine test to all the households and placing posters in the GPs' waiting room. Out of 195 headache patients recruited, 92% had migraine while 73% had never consulted a physician for headache. The aim of this study was to evaluate the long-term impact of this campaign. The follow-up was performed by a telephone interview. The questionnaire considered the characteristics of headache, quality of life, preventive and acute treatments, drug efficacy, comorbidity and subjective usefulness of the campaign. Of the 179 migraineurs, 90.5% (mean age 40.7 +/- 16.5, 139 females) were included in the follow-up. An improvement was observed in mean pain intensity (-13.9%; p < 0.0001) and mean HIT-6 score (-6.1%; p = 0.0003). The campaign was considered to be useful by 63.6% of cases, while 66.1% reported an improvement in their clinical status. Improved patients showed a decreased mean number of days with headache per month (-51.7%; p < 0.0001), pain intensity (-21.8%; p < 0.0001), headache duration (-18.1%; p = 0.0008)and HIT-6 score (-11.7%; p < 0.0001). Our data suggest that the effects of a "single shot" campaign are beneficial not only in a short-term perspective, but even in the longterm. Moreover, the lack of benefit in more severe cases suggests that such patients should not be treated by GPs alone: patients in whom the HIT-6 score, frequency,severity or duration of headache worsen should be promptly referred to the headache clinic.
Similar articles
-
The effects of a sensitisation campaign on unrecognised migraine: the Casilino study.J Headache Pain. 2007 Sep;8(4):205-8. doi: 10.1007/s10194-007-0395-6. Epub 2007 Sep 24. J Headache Pain. 2007. PMID: 17901925 Free PMC article.
-
Impact of a public sensitization campaign on migraine management in France.J Headache Pain. 2009 Aug;10(4):241-7. doi: 10.1007/s10194-009-0128-0. Epub 2009 May 30. J Headache Pain. 2009. PMID: 19484351 Free PMC article.
-
"The Headache Week": a useful tool to highlight "invisible" migraineurs.J Headache Pain. 2005 Oct;6(5):422-3. doi: 10.1007/s10194-005-0238-2. Epub 2005 Sep 21. J Headache Pain. 2005. PMID: 16362718 Free PMC article. No abstract available.
-
Revised guidelines of the French Headache Society for the diagnosis and management of migraine in adults. Part 1: Diagnosis and assessment.Rev Neurol (Paris). 2021 Sep;177(7):725-733. doi: 10.1016/j.neurol.2021.07.001. Epub 2021 Jul 30. Rev Neurol (Paris). 2021. PMID: 34340812 Review.
-
Efficacy and Safety of Galcanezumab for the Preventive Treatment of Migraine: A Narrative Review.Adv Ther. 2020 May;37(5):2034-2049. doi: 10.1007/s12325-020-01319-9. Epub 2020 Apr 21. Adv Ther. 2020. PMID: 32319039 Free PMC article. Review.
Cited by
-
A study of migraine characteristics in joint hypermobility syndrome a.k.a. Ehlers-Danlos syndrome, hypermobility type.Neurol Sci. 2015 Aug;36(8):1417-24. doi: 10.1007/s10072-015-2173-6. Epub 2015 Mar 20. Neurol Sci. 2015. PMID: 25791889
-
Categorization and comparison of patients suffering from migraines without aura or other headaches in primary health care centers in Bosnia and Herzegovina: a cross-sectional, multi-centered, prospective study.Hippokratia. 2023 Jul-Sep;27(3):99-105. Hippokratia. 2023. PMID: 39119362 Free PMC article.
References
-
- Lipton RB, Scher AI, Kolodner K, Liberman J, Steiner TJ, Stewart WF. Migraine in the United States: epidemiology and patterns of health care use. Neurology. 2002;58:885–894. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical